Komori
General Meetings of Shareholders7459MEDIPAL HOLDINGS CORPORATIONTrading & Wholesale

Notice of Convocation of an Extraordinary General Meeting of Shareholders

In preparation for an extraordinary general meeting of shareholders, 1 amendment to the Articles of Incorporation and 3 shareholder proposals will be submitted for consideration. The Board of Directors has expressed its opposition to shareholder Proposals No. 2 through No. 4.

Worth reading
87Important
Scored from 3 of 4 sections
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Resolutions for the General Meeting of Shareholders

Extraordinary
2026
Dec 15
Date and time(Tuesday)27 days from this disclosure to the meeting
Matters for resolution4 items (3 from the company, 1 from shareholders)
  1. Partial Amendment to the Articles of Incorporation

    Shareholder Proposal
  2. Matter concerning the dismissal of Director Watanabe Shuichi (渡辺秀一)

  3. Matter concerning the distribution of surplus (special dividend)

  4. Acquisition of treasury shares

Shareholder Proposal

A shareholder proposal has been submitted by a proposing shareholder. Proposal No. 1 is both a company proposal and a shareholder proposal, while Proposals No. 2 through No. 4 are shareholder proposals. The Board of Directors opposes Proposals No. 2 through No. 4.

A shareholder proposal is a resolution submitted by a shareholder, rather than by the company.
Resolutions for the General Meeting of Shareholders
ItemDetails
Type of shareholders' meetingExtraordinary
Date and time10:00 a.m., 15 December 2026 (Tuesday)
Matters for resolutionProposal No. 1: Partial Amendment to the Articles of Incorporation, Proposal No. 2: Matter concerning the dismissal of Director Watanabe Shuichi (渡辺秀一), Proposal No. 3: Matter concerning the distribution of surplus (special dividend), Proposal 4: Acquisition of treasury shares
Shareholder ProposalA shareholder proposal has been submitted by a proposing shareholder. Proposal No. 1 is both a company proposal and a shareholder proposal, while Proposals No. 2 through No. 4 are shareholder proposals. The Board of Directors opposes Proposals No. 2 through No. 4.
Items this document does not state (2)
Director nomineePercentage voting in favor

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

An extraordinary general meeting of shareholders will be held at the request of shareholders. The Board of Directors opposes Proposal No. 2 on the grounds that a smooth transition to the new management structure and the experience and knowledge of Watanabe Shuichi (渡辺秀一) are necessary, Proposal No. 3 on the grounds that securing growth investment opportunities must be balanced with stable shareholder returns, and Proposal No. 4 on the grounds of maintaining financial soundness and a stable supply of pharmaceuticals and other products.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.